𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Circadian-system alterations during cancer processes: A review

✍ Scribed by M.C. Mormont; F. Lévi

Publisher
John Wiley and Sons
Year
1997
Tongue
French
Weight
129 KB
Volume
70
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Murine and human data have indicated that tumors and tumor-bearing hosts may exhibit nearly normal or markedly altered circadian rhythms. Amplitude damping, phase shifts, and/or period (tau) change, including appearance of ultradian rhythms (with tau < 20 hr) usually become more prominent at late stages of cancer development. The extent of rhythm alterations also varies according to tumor type, growth rate and level of differentiation. While "group chronotherapy," i.e., administration of the same chronomodulated schedule to cancer patients, has increased chemotherapy efficacy and/or tolerability, cancer patients' individual circadian rhythms now need to be explored on a large scale, in order to estimate the incidence of cancer-associated circadian-system alterations and to understand the underlying mechanisms. Correlations between such alterations and patient outcome must be established in order to specify the need for individualized chronomodulated delivery schedules and/or specific rhythm-oriented therapy, especially in patients with circadian-system disturbances.

📜 SIMILAR VOLUMES

Cytogenetic alterations in nonmelanoma s
Cytogenetic alterations in nonmelanoma skin cancer: A review
✍ Kevin J. Ashton; Melanie A. Carless; Lyn R. Griffiths 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

## Abstract Since the advent of cytogenetic analysis, knowledge about fundamental aspects of cancer biology has increased, allowing the processes of cancer development and progression to be more fully understood and appreciated. Classical cytogenetic analysis of solid tumors had been considered dif

The urokinase-type plasminogen activator
The urokinase-type plasminogen activator system in cancer metastasis: A review
✍ Peter A. Andreasen; Lars Kjøller; Lise Christensen; Michael J. Duffy 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 398 KB 👁 1 views

The urokinase-type plasminogen activator (u-PA) system consists of the serine proteinases plasmin and u-PA; the serpin inhibitors a 2 -anti-plasmin, PAI-1 and PAI-2; and the u-PA receptor (u-PAR). Two lines of evidence have strongly suggested an important and apparently causal role for the u-PA syst

Use of a yeast assay to detect functiona
Use of a yeast assay to detect functional alterations inp53 in prostate cancer: Review and future directions
✍ deVere White, Ralph W.; Deitch, Arline D.; Gumerlock, Paul H.; Shi, Xu-Bao 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

## BACKGROUND. While many studies have suggested that p53 mutations are common in human cancers, the functional activity of these mutant alleles has not yet been fully addressed. We believe that information about the functional status of individual p53 mutants will prove to be important for a bette